查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1830997

生育服務市場

Fertility Services Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

生育服務市場預計將從 2024 年的 357.9 億美元擴大到 2031 年的 671.2 億美元，2025-2031 年期間的複合年成長率預計為 9.3%。

市場洞察與分析師觀點：生育服務市場的成長可歸因於多種因素，包括醫療服務的可及性和可用性的提高；透過ICSI技術提高精子品質差的男性進行體外受精（IVF）的成功率；以及醫療保健和研究投入的增加。此外，多囊性卵巢症候群（PCOS）、子宮內膜結核和性傳染病（STD）等不孕症相關疾病的發生率不斷上升，也推動了市場的成長。人們對不孕症問題的認知不斷提高以及醫療設施可近性的改善，也增加了已開發國家和新興國家對這些服務的需求。近年來，不孕症相關健康問題的激增顯著推動了全球市場的發展。其他促成因素包括可支配收入的增加、靈活的醫療保險覆蓋範圍選擇以及透過電視和網路平台推廣生殖服務的增加。該報告還根據生育服務市場的當前趨勢（例如生育服務的推出和批准數量增加以及技術的進步）重點介紹了成長機會。

成長動力：婦科疾病發生率上升推動市場擴張輸卵管阻塞等疾病通常由未治療的性傳染感染、流產併發症、產後感染和外科手術引起，可導致女性不孕。子宮內膜結核、多囊性卵巢症候群和性傳染病等導致不孕的各種疾病的盛行率不斷上升，這推動了生育服務市場的成長。根據 2022 年 8 月發表在《Cureus 雜誌》上的一項研究，全球女性多囊性卵巢症候群的盛行率估計在 4% 到 20% 之間。世界衛生組織 (WHO) 報告稱，2021 年，全球有超過 1.16 億女性 (3.4%) 患有多囊性卵巢症候群。此外，《柳葉刀》2020 年的一篇文章估計，中國有 2,400 萬名女性患有多囊性卵巢症候群。這種情況增加了對 IVF 和各種輔助生殖技術 (ART) 的需求，從而推動了生育服務市場的成長。

策略洞察報告細分和範圍：生育服務市場分析是基於程序、患者類型、最終用戶和地理。市場按程序細分為輔助生殖技術、人工授精和生育手術。依患者類型分為男性和女性。就最終用戶而言，市場細分為生育中心、醫院和外科診所以及其他。

細分分析：依程序分類，生育服務市場分為輔助生殖技術、人工授精及生育手術。輔助生殖技術細分市場在2023年佔據最大市場佔有率，預計在2023年至2031年期間將呈現最高複合年成長率。此細分市場進一步細分為體外受精、卵胞漿內單一精子注射和代孕。

生育服務市場依患者類型分類，分為男性和女性兩部分。 2023年，女性市場佔據了更大的市場佔有率，而男性市場預計在預測期內將經歷更高的複合年成長率。壓力增加、肥胖、吸煙和飲酒等因素會導致男性不孕。此外，生育服務意識的提高、研發支出的增加、主要市場參與者推出新產品的舉措以及生活方式的改變，都在推動男性市場的成長。

就最終用戶而言，生育服務市場細分為生育中心、醫院及外科診所及其他。生育中心在2023年佔據了最大的市場佔有率，預計在預測期內將實現最高的複合年成長率。全球生育診所數量的成長以及技術的進步正在推動該細分市場的持續成長。此外，已開發國家和新興國家對不孕症治療的認知不斷提高，導致全球生育治療診所的數量增加，進一步推動了市場的成長。能夠治療不孕症的專業人員數量的不斷增加、可支配收入的提高以及印度和中國等發展中國家持牌生育診所數量的不斷增加，也促進了生育中心細分市場的成長。

區域分析 - 生育服務市場：生育服務市場報告涵蓋北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國、印度、日本、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國和其他中東和其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲（巴西、阿根廷和南美洲和其他中美洲地區）。由於各種不孕症藥物的推出和快速分銷以及不孕症領域研究活動的增加，亞太地區在 2023 年佔據了最大的市場佔有率。

2023 年，歐洲在生育服務市場佔有率方面排名第三。該地區的市場分為德國、英國、義大利、西班牙、法國和歐洲其他地區。眾多國內市場參與者和不斷上升的不孕症發病率是推動該地區市場成長的關鍵因素。德國是該地區市場的重要貢獻者。歐洲擁有全球 40% 的 IVF 診所，這是歐洲生育測試和治療市場成功的關鍵因素。此外，該地區吸引了全球領導者的大量投資。歐洲市場的整體前景是積極的，先進的 IVF 技術吸引了私募股權公司的大量投資。此外，DIY 測試改善了不孕症測試和治療的可及性並降低了相關成本，預計這兩者都將在未來幾年為市場成長創造豐厚的機會。

預計亞太地區生育服務市場將在2021年至2031年期間實現最快的複合年成長率。該地區的市場細分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。中國的成長得益於醫療旅遊業的蓬勃發展和醫療基礎設施的改善，預計這些因素將推動該地區生育服務的普及。此外，市場參與者在開發各種生育服務方面取得的技術進步也有望推動成長。預計未來幾年，先進生育服務產品的推出和獲批數量的增加將進一步促進區域市場的成長。由於不孕症率上升、晚孕趨勢加劇、試管嬰兒成功率提高以及可支配收入的成長，預計亞太地區市場在預測期內將經歷顯著成長。試管嬰兒是幫助不孕症族群（包括單親媽媽、夫婦和LGBT族群）最常用的方法之一。此外，由於生育旅遊業的興起，亞太地區的試管嬰兒治療市場具有永續發展的潛力。預計市場的成長也將受到生育診所數量的增加和新興地區的擴張機會的支持。

生育服務市場報告範圍產業發展與未來機會 - 生育服務市場：根據生育服務市場領先公司的新聞稿，以下重點介紹了幾項措施：

2022 年 10 月，Indira IVF 與 Maven Clinic 合作，後者是一家美國公司，專門透過基於遠距醫療的虛擬診所致力於女性和家庭健康。此次合作旨在讓印度的 Maven 會員能夠透過 Maven 平台享受 Indira IVF 的高品質臨床護理和其他福利。 2022 年 8 月，Genea Fertility 擔任澳洲猶太生育網路 (AJFN) 年度主要募款活動的白金贊助商。 2021 年 12 月，領先的女性健康解決方案提供商 Cooper Surgical 以 16 億美元收購了 Generate Life Sciences，增強了其在生育和婦產科中心的服務能力。 2021 年 7 月，全球輔助生殖技術研究供應商 Hamilton Throne Ltd. 以 800 萬美元收購了 IVFTECH ApS (IVFtech) 及其子公司 K4 Technology ApS，專注於用於輔助生殖技術的大容量層流工作站和孵化器。 2021 年 5 月，輔助生殖服務 (ARS) 的全球領導者 Virtus Health 宣布與澳洲生物技術和數位健康公司 Drop Bio 建立策略合作，以提高精準生育服務。 2021 年 2 月，Cooper Surgical 宣布與 Virtus Health 建立多年期策略合作關係，以推動生育治療的創新和進步。 2020 年 11 月，Ferring BV 和 Igenomix 達成了一項為期四年的研究合作，為受懷孕相關疾病影響的患者開發新型治療產品。競爭格局和主要公司－生育服務市場：生育服務市場的主要參與者包括 CooperSurgical, Inc.；Vitrolife；Cook Medical；Care Fertility；INVO Bioscience；Carolinas Fertility Institute；Genea Limited；Merck KgaA；LABOTECT GmbH；和 Monash IVF Group Limited。這些公司專注於開發新技術、改進現有產品並擴展地域以滿足不斷成長的全球需求。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：生育服務市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：生育服務市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：生育服務市場－全球市場分析

  • 生育服務 - 全球市場概覽
  • 生育服務－全球市場及2031年預測

第7章：生育服務市場-收入分析-依程序，2021-2031

  • 概述
  • 輔助生殖技術
  • 人工授精
  • 生育手術

第 8 章：生育服務市場 - 收入分析 - 依病患類型，2021-2031 年

  • 概述
  • 男性
  • 女性

第9章：生育服務市場-收入分析-按最終用戶，2021-2031

  • 概述
  • 生育診所
  • 醫院和外科診所
  • 其他

第 10 章：生育服務市場 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 12 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 13 章：生育服務市場 - 主要公司簡介

  • CooperSurgical, Inc
  • Vitrolife
  • Cook Medical
  • Care Fertility
  • INVO Bioscience
  • Carolinas Fertility Institute
  • Genea Limited
  • Merck KGaA
  • LABOTECT GmbH
  • Monash IVF Group Limited

第 14 章：附錄

簡介目錄
Product Code: TIPRE00004739

The fertility services market is anticipated to expand from US$ 35.79 billion in 2024 to US$ 67.12 billion by 2031, with a projected CAGR of 9.3% during the period of 2025-2031.

Market Insights and Analyst Perspective:The growth of the fertility services market can be attributed to several factors, including improved accessibility and availability of healthcare services; enhanced success rates of in vitro fertilization (IVF) through ICSI for men with poor sperm quality; and increased investment in healthcare and research. Additionally, the rising incidence of infertility-related medical conditions such as polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs) is propelling market growth. Growing awareness about infertility and better access to healthcare facilities have also heightened the demand for these services in both developed and emerging nations. The surge in infertility-related health issues has significantly boosted the global market in recent years. Other contributing factors include rising disposable incomes, flexible health insurance coverage options, and increased marketing of reproductive services via television and online platforms. The report also highlights growth opportunities in light of current trends in the fertility services market, such as the rise in launches and approvals for fertility services and advancements in technology.

Growth Drivers:Rising Incidence of Gynecological Disorders Fuels Market Expansion

Conditions like blocked fallopian tubes, often resulting from untreated STIs, complications from abortions, postpartum infections, and surgical procedures, can lead to infertility in women. The increasing prevalence of various diseases, including endometrial tuberculosis, PCOS, and STDs, that contribute to infertility is driving the growth of the fertility services market. According to a study published in the Cureus Journal in August 2022, the global prevalence of PCOS among women is estimated to range from 4% to 20%. The World Health Organization (WHO) reported that in 2021, PCOS affected over 116 million women (3.4%) worldwide. Furthermore, a 2020 article in The Lancet estimated that 24 million women in China suffer from PCOS. This situation is increasing the demand for IVF and various assisted reproductive technologies (ART), thereby driving the growth of the fertility services market.

Strategic Insights

Report Segmentation and Scope:The analysis of the fertility services market is conducted based on procedure, patient type, end user, and geography. The market is segmented by procedure into assisted reproductive technology, artificial insemination, and fertility surgeries. By patient type, it is divided into male and female categories. Regarding end users, the market is segmented into fertility centers, hospitals & surgical clinics, and others.

Segmental Analysis:In terms of procedure, the fertility services market is divided into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment held the largest market share in 2023 and is expected to exhibit the highest CAGR from 2023 to 2031. This segment is further divided into in vitro fertilization, intracytoplasmic sperm injection, and surrogacy.

The fertility services market, categorized by patient type, is split into male and female segments. The female segment accounted for a larger market share in 2023, while the male segment is projected to experience a higher CAGR during the forecast period. Factors such as increased stress, obesity, smoking, and alcohol consumption contribute to male infertility. Additionally, rising awareness of fertility services, increased R&D spending, initiatives by key market players to launch new products, and changing lifestyles are driving growth in the male segment.

In terms of end users, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is expected to register the highest CAGR during the forecast period. The growth in the number of fertility clinics globally, along with technological advancements, is propelling the market growth for this segment. Furthermore, increasing awareness of infertility treatments in both developed and emerging countries has led to a rise in the number of fertility treatment clinics worldwide, further driving market growth. The growing number of professionals capable of treating infertility, rising disposable incomes, and the increasing number of licensed fertility clinics in developing countries like India and China also contribute to the growth of the fertility centers segment.

Regional Analysis - Fertility Services Market:The fertility services market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific held the largest market share in 2023 due to the introduction and rapid distribution of various infertility medications and increased research activities in the field of infertility.

Europe ranked third in terms of market share for fertility services in 2023. The market in this region is segmented into Germany, the UK, Italy, Spain, France, and the Rest of Europe. The presence of numerous domestic market players and the rising incidence of infertility are key factors driving market growth in this region. Germany is a significant contributor to the regional market. Europe is home to 40% of all IVF clinics globally, which has been a crucial factor in the success of the European fertility testing and treatment market. Additionally, the region has attracted substantial investments from global leaders. The overall outlook for the European market is positive, with advanced IVF technology drawing significant investment from private equity firms. Moreover, do-it-yourself testing has improved access and reduced the costs associated with infertility testing and treatment, both of which are expected to create lucrative opportunities for market growth in the coming years.

The fertility services market in Asia Pacific is projected to achieve the fastest CAGR from 2021 to 2031. The market in this region is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The growth in China is driven by increasing medical tourism and enhancements in healthcare infrastructure, which are expected to boost the adoption of fertility services in the region. Additionally, technological advancements in developing various fertility services by market players are anticipated to drive growth. An increase in product launches and approvals for advanced fertility services is expected to further enhance regional market growth in the coming years. Due to rising infertility rates, a trend towards later pregnancies, improved IVF success rates, and growing disposable incomes, the market in Asia Pacific is expected to experience significant growth during the forecast period. IVF is one of the most commonly utilized methods to assist individuals affected by infertility, including single mothers, couples, and members of the LGBT community. Furthermore, the IVF treatment market in Asia Pacific has sustainable development potential due to the rise in fertility tourism. The growth of the market is also expected to be supported by the increasing number of fertility clinics and expansion opportunities in emerging regions.

Fertility Services Market Report Scope

Industry Developments and Future Opportunities - Fertility Services Market:According to press releases from leading companies in the fertility services market, several initiatives are highlighted below:

In October 2022, Indira IVF partnered with Maven Clinic, a US-based company specializing in women's and family health through telemedicine-based virtual clinics. This collaboration aims to provide Maven members in India with access to Indira IVF's high-quality clinical care and other benefits through the Maven platform.In August 2022, Genea Fertility served as a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.In December 2021, Cooper Surgical, a leading provider of women's health solutions, acquired Generate Life Sciences for US$1.6 billion, enhancing its offerings in fertility and OB/GYN centers.

In July 2021, Hamilton Throne Ltd., a global provider of ART research, acquired IVFTECH ApS (IVFtech) and its subsidiary K4 Technology ApS for US$8 million, focusing on large-capacity laminar flow workstations and incubators for ART.In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic collaboration with Drop Bio, an Australian biotechnology and digital health company, to advance precision fertility delivery.

In February 2021, Cooper Surgical announced a multi-year strategic collaboration with Virtus Health to drive innovation and advancements in fertility treatment.In November 2020, Ferring B.V. and Igenomix entered into a four-year research collaboration to develop novel therapeutic products for patients affected by pregnancy-related diseases.

Competitive Landscape and Key Companies - Fertility Services Market:Key players in the fertility services market include CooperSurgical, Inc.; Vitrolife; Cook Medical; Care Fertility; INVO Bioscience; Carolinas Fertility Institute; Genea Limited; Merck KgaA; LABOTECT GmbH; and Monash IVF Group Limited. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Fertility Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Fertility Services Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Fertility Services Market - Global Market Analysis

  • 6.1 Fertility Services - Global Market Overview
  • 6.2 Fertility Services - Global Market and Forecast to 2031

7. Fertility Services Market - Revenue Analysis (USD Million) - By Procedure, 2021-2031

  • 7.1 Overview
  • 7.2 Assisted Reproductive Technology
    • 7.2.1 In Vitro Fertilization (IVF)
    • 7.2.2 Intracytoplasmic Sperm Injection
  • 7.3 Artificial Insemination
    • 7.3.1 Intrauterine Insemination
    • 7.3.2 Intracervical Insemination
    • 7.3.3 Intratubal Insemination
  • 7.4 Fertility Surgeries

8. Fertility Services Market - Revenue Analysis (USD Million) - By Patient Type, 2021-2031

  • 8.1 Overview
  • 8.2 Male
  • 8.3 Female

9. Fertility Services Market - Revenue Analysis (USD Million) - By End-User, 2021-2031

  • 9.1 Overview
  • 9.2 Fertility Clinics
  • 9.3 Hospitals and Surgical Clinics
  • 9.4 Others

10. Fertility Services Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Fertility Services Market Overview
    • 10.1.2 North America Fertility Services Market Revenue and Forecasts to 2031
    • 10.1.3 North America Fertility Services Market Revenue and Forecasts and Analysis - By Procedure
    • 10.1.4 North America Fertility Services Market Revenue and Forecasts and Analysis - By Patient Type
    • 10.1.5 North America Fertility Services Market Revenue and Forecasts and Analysis - By End-User
    • 10.1.6 North America Fertility Services Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.7.1 United States Fertility Services Market
        • 10.1.7.1.1 United States Fertility Services Market, by Procedure
        • 10.1.7.1.2 United States Fertility Services Market, by Patient Type
        • 10.1.7.1.3 United States Fertility Services Market, by End-User
      • 10.1.7.2 Canada Fertility Services Market
        • 10.1.7.2.1 Canada Fertility Services Market, by Procedure
        • 10.1.7.2.2 Canada Fertility Services Market, by Patient Type
        • 10.1.7.2.3 Canada Fertility Services Market, by Donor Type
        • 10.1.7.2.3 Canada Fertility Services Market, by End-User
      • 10.1.7.3 Mexico Fertility Services Market
        • 10.1.7.3.1 Mexico Fertility Services Market, by Procedure
        • 10.1.7.3.2 Mexico Fertility Services Market, by Patient Type
        • 10.1.7.3.3 Mexico Fertility Services Market, by End-User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East & Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East & Africa
  • 10.5 South & Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South & Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Fertility Services Market - Key Company Profiles

  • 13.1 CooperSurgical, Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Vitrolife
  • 13.3 Cook Medical
  • 13.4 Care Fertility
  • 13.5 INVO Bioscience
  • 13.6 Carolinas Fertility Institute
  • 13.7 Genea Limited
  • 13.8 Merck KGaA
  • 13.9 LABOTECT GmbH
  • 13.10 Monash IVF Group Limited

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud